Literature DB >> 16047227

The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls.

Hans-Olov Hellström1, Bengt Mjöberg, Hans Mallmin, Karl Michaëlsson.   

Abstract

Aluminum is considered a potentially toxic metal, and aluminum poisoning may lead to three types of disorders: aluminum-induced bone disease, microcytic anemia and encephalopathy. This is well known in patients with chronic renal failure, but since healthy subjects with normal renal function retain 4% of the aluminum consumed, they are also at risk of long-term low-grade aluminum intoxication. Included in this study were a total of 172 patients (age range 16-98 years) with the aim of examining whether aluminum accumulates in bone with increasing age. Additionally, we aimed to investigate whether the aluminum content of bone differs between controls and hip fracture cases with and without dementia, in particular in those with Alzheimer's disease. During operations for all cases, bone biopsies were taken with an aluminum-free instrument from the trabecular bone. The samples were measured for their content of aluminum using an inductively coupled mass spectrometer. We found an exponential increase in aluminum content of bone with age. The average aluminum values, adjusted for age, were similar in men and women (P=0.46). No significant differences in sex- and age-adjusted mean aluminum values between the controls and the hip fracture cases with (P=0.72) and without (P=0.33) dementia could be detected. The average aluminum concentration among cases with Alzheimer's disease was also similar to the values of hip fracture patients with other types of dementia (P=0.47). Odds ratios of hip fracture for each quartile of aluminum content in bone were also estimated to detect non-linear effects, but we did not find any statistically significant association remaining after age and sex adjustment. Thus, our results indicate that we accumulate aluminum in bone over our life span, but this does not seem to be of major pathogenetic significance for the occurrence of hip fracture or dementia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047227     DOI: 10.1007/s00198-005-1981-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  50 in total

1.  Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator mass spectrometry.

Authors:  P B Moore; J P Day; G A Taylor; I N Ferrier; L K Fifield; J A Edwardson
Journal:  Dement Geriatr Cogn Disord       Date:  2000 Mar-Apr       Impact factor: 2.959

Review 2.  Aluminium toxicokinetics: an updated minireview.

Authors:  R A Yokel; P J McNamara
Journal:  Pharmacol Toxicol       Date:  2001-04

Review 3.  Intestinal absorption of aluminium in renal failure.

Authors:  Tilman B Drüeke
Journal:  Nephrol Dial Transplant       Date:  2002       Impact factor: 5.992

4.  Aluminum metabolism and toxicity in uremia.

Authors:  A C Alfrey
Journal:  J UOEH       Date:  1987-03-20

5.  Letter: The myth of aluminum toxicity.

Authors:  D J Sherrard
Journal:  N Engl J Med       Date:  1974-03-28       Impact factor: 91.245

Review 6.  Aluminum.

Authors:  A C Alfrey
Journal:  Adv Clin Chem       Date:  1983       Impact factor: 5.394

7.  Hyperaluminaemia from aluminium resins.

Authors:  G M Berlyne
Journal:  Lancet       Date:  1970-12-12       Impact factor: 79.321

8.  Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients.

Authors:  P C D'Haese; M M Couttenye; L V Lamberts; M M Elseviers; W G Goodman; I Schrooten; W E Cabrera; M E De Broe
Journal:  Clin Chem       Date:  1999-09       Impact factor: 8.327

9.  Falls and fractures in patients with Alzheimer-type dementia.

Authors:  D M Buchner; E B Larson
Journal:  JAMA       Date:  1987-03-20       Impact factor: 56.272

10.  Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition.

Authors:  S M Ott; N A Maloney; G L Klein; A C Alfrey; M E Ament; J W Coburn; D J Sherrard
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

View more
  6 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

Review 2.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

3.  Luminescent Fluorene-Based Bis-Pyrazolyl Aniline Ligand for Aluminum Detection.

Authors:  Andrew Frazer; Alma R Morales; Adam W Woodward; Paul Tongwa; Tatiana Timofeeva; Kevin D Belfield
Journal:  J Fluoresc       Date:  2013-09-29       Impact factor: 2.217

4.  Trace and macro elements in the femoral bone as indicators of long-term environmental exposure to toxic metals in European brown bear (Ursus arctos) from Croatia.

Authors:  Maja Lazarus; Tatjana Orct; Slaven Reljić; Marija Sedak; Nina Bilandžić; Jasna Jurasović; Đuro Huber
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-21       Impact factor: 4.223

5.  No association between the aluminium content of trabecular bone and bone density, mass or size of the proximal femur in elderly men and women.

Authors:  Hans-Olov Hellström; Bengt Mjöberg; Hans Mallmin; Karl Michaëlsson
Journal:  BMC Musculoskelet Disord       Date:  2006-08-23       Impact factor: 2.362

Review 6.  Interest of Bone Histomorphometry in Bone Pathophysiology Investigation: Foundation, Present, and Future.

Authors:  Pascale Chavassieux; Roland Chapurlat
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.